Salix Pharmaceuticals, Ltd. Release: FDA Assigns September 29, 2014 Prescription Drug User Fee Act Goal Date For RELISTORA Subcutaneous Injection Snda For The Treatment Of Opioid-Induced Constipation In Patients With Chronic Non-Cancer Pain RALEIGH, N.C. & TARRYTOWN, N.Y.-- --Salix Pharmaceuticals, Ltd. and Progenics Pharmaceuticals today announced ... (more)
http://ift.tt/1uiLYKz
http://ift.tt/1uiLYKz
No comments:
Post a Comment